239 related articles for article (PubMed ID: 32395200)
41. Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma.
Alcalay J; Tauber G; Fenig E; Hodak E
J Drugs Dermatol; 2015 Mar; 14(3):219-23. PubMed ID: 25738842
[TBL] [Abstract][Full Text] [Related]
42. Idiopathic basal cell carcinoma in children.
Alcalay J; Ben-Amitai D; Alkalay R
J Drugs Dermatol; 2008 May; 7(5):479-81. PubMed ID: 18505143
[TBL] [Abstract][Full Text] [Related]
43. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.
Narayanan K; Hadid OH; Barnes EA
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD007041. PubMed ID: 25503105
[TBL] [Abstract][Full Text] [Related]
44. Favourable results of Mohs micrographic surgery for basal cell carcinoma.
Gniadecki R; Glud M; Mortensen K; Bang B; Biskup E; Omland SH
Dan Med J; 2015 Dec; 62(12):A5171. PubMed ID: 26621396
[TBL] [Abstract][Full Text] [Related]
45. Treatment of periocular basal cell carcinoma using an advanced stereotactic device.
Pontoriero A; Iatì G; Conti A; Minutoli F; Bottari A; Pergolizzi S; De Renzis C
Anticancer Res; 2014 Feb; 34(2):873-5. PubMed ID: 24511025
[TBL] [Abstract][Full Text] [Related]
46. Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature.
Attili SK; Ibbotson SH; Fleming C
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):68-79. PubMed ID: 22409709
[TBL] [Abstract][Full Text] [Related]
47. Staged excision of primary periocular basal cell carcinoma: absence of residual tumour in re-excised specimens: a 10-year series.
McGrath LA; Meeney A; Currie ZI; Mudhar HS; Tan JH
Br J Ophthalmol; 2019 Jul; 103(7):976-979. PubMed ID: 30181140
[TBL] [Abstract][Full Text] [Related]
48. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
49. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.
Narayanan K; Hadid OH; Barnes EA
Cochrane Database Syst Rev; 2009 Apr; (2):CD007041. PubMed ID: 19370670
[TBL] [Abstract][Full Text] [Related]
50. Periocular microcystic adnexal carcinoma: management and outcome with Mohs' micrographic surgery.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Ophthalmologica; 2006; 220(2):109-13. PubMed ID: 16491033
[TBL] [Abstract][Full Text] [Related]
51. Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited.
Told R; Reumueller A; Kreminger J; Lackner B; Kuchar A; Schmidt-Erfurth U; Dunavoelgyi R
Wien Klin Wochenschr; 2024 Feb; ():. PubMed ID: 38349412
[TBL] [Abstract][Full Text] [Related]
52. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
53. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.
Narayanan K; Hadid OH; Barnes EA
Cochrane Database Syst Rev; 2012 Feb; (2):CD007041. PubMed ID: 22336828
[TBL] [Abstract][Full Text] [Related]
54. Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib.
Su MG; Potts LB; Tsai JH
Am J Ophthalmol Case Rep; 2020 Sep; 19():100755. PubMed ID: 32490287
[TBL] [Abstract][Full Text] [Related]
55. Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India.
Vijay V; Alam MS; Subramanian N; Krishnakumar S; Biswas J; Mukherjee B
Oman J Ophthalmol; 2020; 13(3):129-135. PubMed ID: 33542600
[TBL] [Abstract][Full Text] [Related]
56. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
57. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma.
Ally MS; Aasi S; Wysong A; Teng C; Anderson E; Bailey-Healy I; Oro A; Kim J; Chang AL; Tang JY
J Am Acad Dermatol; 2014 Nov; 71(5):904-911.e1. PubMed ID: 24929884
[TBL] [Abstract][Full Text] [Related]
58. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
59. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
[TBL] [Abstract][Full Text] [Related]
60. Basal cell carcinoma involving the lacrimal canaliculus. A documented mechanism of tumor spread.
Fosko SW; Gibney MD; Holds JB
Dermatol Surg; 1997 Mar; 23(3):203-6. PubMed ID: 9145964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
